NCT05763615 (IMAG 2 ORL) is a NA clinical trial of Tractography MRI in Head and Neck Neoplasms, sponsored by Assistance Publique - Hôpitaux de Paris.

Who is sponsoring NCT05763615?

NCT05763615 is sponsored by Assistance Publique - Hôpitaux de Paris.

What drugs are being tested in NCT05763615?

Interventions in NCT05763615: Tractography MRI.

What condition does NCT05763615 study?

NCT05763615 studies Head and Neck Neoplasms, Congenital Abnormalities.

Is NCT05763615 still recruiting?

NCT05763615 is currently completed. Last updated 29 January 2026.

Last reviewed 2026-01-29 · How we verify

NCT05763615: IMAG 2 ORL

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

3D Modeling of the Cervico-facial Region and Cranial Nerve Tractography: IMAG 2 ORL Project

Completed NA Last updated 29 January 2026

What this trial tests

NA trial testing Tractography MRI in Head and Neck Neoplasms in 7 participants. Completed in 4 May 2024.

Timeline

10 May 2023

Primary endpoint
4 May 2024

4 May 2024

Quick facts

Lead sponsor	Assistance Publique - Hôpitaux de Paris
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	other
Enrollment	7
Start date	10 May 2023
Primary completion	4 May 2024
Estimated completion	4 May 2024
Sites	1 location across France

Drugs / interventions tested

Tractography MRI

Conditions studied

Head and Neck Neoplasms — all drugs for Head and Neck Neoplasms →
Congenital Abnormalities — all drugs for Congenital Abnormalities →

Sponsor

Assistance Publique - Hôpitaux de Paris — full company profile →

Who can join

Adults 1 to 5, any sex, with Head and Neck Neoplasms or Congenital Abnormalities. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

3D modeling associated with the tracking of nerve fibers meets the needs of preoperative planning for tumors and cervico-facial congenital malformations. Indeed, these lesions are closely related to the cranial nerves and in particular nerve V (infratemporal fossa), nerve VII (temporal bone, parotido-masseter region), nerves IX, X, XI, XII and the chain cervical sympathetic (infratemporal and cervical regions). The development of a model of this region will therefore improve the surgical management of these children.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Head and Neck Neoplasms

Currently open trials in the same condition.

NCT07491536 — Ozone Therapy With Biomimetic Oral Care for Cancer-Related Oral Mucositis · NA · recruiting
NCT06912087 — Dose Finding Study of Zanzalintinib With Pembrolizumab and Cetuximab in Head and Neck SCC · Phase 1 · recruiting
NCT06998069 — Head and Neck Cancer Study Project in the Geriatric Population · Phase 3 · recruiting
NCT07158164 — DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment · Phase 4 · recruiting
NCT06303180 — NIDCD Otolaryngology Clinical Protocol Biospecimen Bank · recruiting

Other Assistance Publique - Hôpitaux de Paris trials

Trials by the same sponsor.

NCT07443436 — Immunomodulatory Treatment of Interstitial Lung Disease Associated With Surfactant Related Gene Variants · Phase 2 · not yet recruiting
NCT07499492 — Red Blood Cell Transfusion to Optimize Extubation · NA · not yet recruiting
NCT07379918 — Real-life Evaluation of Endopredict® in Early HR+/HER2- Breast Cancer · recruiting
NCT07473869 — Smartphone Application for Automated Measurement of Capillary Refill Time (CRT) · not yet recruiting
NCT07505394 — Efficacy of a Prediction Model-based Algorithm to PREVENT Drug-induced Impulse Control Disorders in Parkinson's Disease · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05763615 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assistance Publique - Hôpitaux de Paris
Last refreshed: 29 January 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05763615.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing